ReportWire

Tag: Industrial Electronics

  • Netherlands Hands Back Control of Chip Maker Nexperia to Chinese Owner

    [ad_1]

    The Dutch government handed back control of semiconductor manufacturer Nexperia to its Chinese owner, moving toward resolving a spat that had blocked vital chip supply to the auto industry.

    Dutch economic-affairs minister Vincent Karremans said Wednesday that the decision had been made in consultation with the Netherlands’ European and international partners and followed recent meetings with Chinese authorities.

    Copyright ©2025 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

    [ad_2]

    Adrià Calatayud

    Source link

  • Chips Held Hostage in Trade War Start Flowing Again to Auto Suppliers

    [ad_1]

    Nexperia microchips are leaving China again, easing a shortage of simple but ubiquitous parts that threatened to paralyze the auto industry.

    German automotive supplier Aumovio, which was recently spun out of tire giant Continental, said Friday that the Sino-Dutch company’s semiconductors and components containing them were on their way from China to Aumovio’s distribution hub in Hungary.

    Copyright ©2025 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

    [ad_2]

    Stephen Wilmot

    Source link

  • How China’s Chokehold on Drugs, Chips and More Threatens the U.S.

    [ad_1]

    BEIJING—China has demonstrated it can weaponize its control over global supply chains by constricting the flow of critical rare-earth minerals. President Trump went to the negotiating table when the lack of Chinese materials threatened American production, and he reached a truce last week with Chinese leader Xi Jinping that both sides say will ease the flow of rare earths.

    But Beijing’s tools go beyond these critical minerals. Three other industries where China has a chokehold—lithium-ion batteries, mature chips and pharmaceutical ingredients—give an idea of what the U.S. would need to do to free itself fully from vulnerability. 

    Copyright ©2025 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

    [ad_2]

    Yoko Kubota

    Source link

  • Exclusive | Trump Officials Torpedoed Nvidia’s Push to Export AI Chips to China

    [ad_1]

    Shortly before President Trump met Chinese leader Xi Jinping in South Korea, an urgent issue emerged. Trump wanted to discuss a request by Nvidia Chief Executive Jensen Huang to allow sales of a new generation of artificial-intelligence chips to China, current and former administration officials said.

    Greenlighting the export of Nvidia’s Blackwell chips would be a seismic policy shift potentially giving China, the U.S.’s biggest geopolitical competitor, a technological accelerant. Huang—who speaks to Trump often—has lobbied relentlessly to maintain access to the Chinese market.

    Copyright ©2025 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

    [ad_2]

    Lingling Wei

    Source link

  • Exclusive | White House to Announce Resumption of Auto Chip Shipments From China

    [ad_1]

    The White House is set to announce that the Dutch semiconductor company that paused shipments weeks ago and risked upending global car production will resume sending chips under a framework agreement reached during talks between President Trump and Chinese leader Xi Jinping, people familiar with the plans said. 

    The new policy on the Dutch chips is part of a forthcoming document from the White House laying out the details of the U.S.-China trade deal signed this week, according to the people.

    Copyright ©2025 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

    [ad_2]

    Ryan Felton

    Source link

  • Broadcom Gets a Stock-Target Increase. Analyst Thinks Anthropic Is a Big, New Customer.

    [ad_1]

    Broadcom Gets a Stock-Target Increase. Analyst Thinks Anthropic Is a Big, New Customer.

    [ad_2]

    Source link

  • Dutch Government Takes Control of Chip Maker From Chinese Parent

    [ad_1]

    The Dutch government wrested control of a Netherlands-based semiconductor company from its Chinese owner, a new flare-up in tensions between China and the West over key technologies and materials.

    Officials at the Dutch Economic Affairs Ministry said Sunday that they had assumed the power to block or reverse decisions at Nexperia 600745 -10.00%decrease; red down pointing triangle, which is owned by China’s Wingtech Technology, to keep Europe from losing “technological knowledge and capabilities” necessary for its economic security.

    Copyright ©2025 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

    [ad_2]

    Sam Schechner

    Source link

  • As Nvidia prepares to post results, these three Europe chip names are tipped for gains, JPMorgan says

    As Nvidia prepares to post results, these three Europe chip names are tipped for gains, JPMorgan says

    [ad_1]

    As Nvidia prepares to publish its much-anticipated full-year results this Wednesday, analysts at JPMorgan say VAT Group, ASML Holding, and ASM International all offer the strongest prospects for investors seeking to cash in on an upturn in the market for microchips. 

    JPMorgan analysts led by Sandeep Deshpande explained that while the slump in the microchip market is now showing signs of improvement, certain segments of the market — including those that supply chips to the auto and industrial sectors — are improving more slowly than others.

    The market for memory chips is, meanwhile, giving off signals of a bumper recovery, with inventory levels for the microchips used in computer storage devices currently sitting at lower than average seasonal levels, they said in a note to clients that published Monday. 

    As such, those Europe-based semiconductor companies least exposed to the autos and industrial sectors, which have the highest exposure to the market for memory chips, are set to see the biggest benefits in the near term, said Deshpande and the team.

    Swiss company VAT Group
    VACN,
    +0.37%

    makes vacuum valves used in chip manufacturing, while Dutch firms ASML Holding
    ASML,
    -0.10%

    ASML,
    -1.73%

    and ASM International
    ASM,
    -2.13%

    both make the lithography machines used to manufacture semiconductors. 

    Shares in all three European companies are up significantly over the previous 12 months — VAT has gained 51%, ASML 43% and ASM 81%.

    Notably, all three European companies are all focused on making the equipment used to manufacture the advanced microchips used in electronic products, including smartphones and personal computers. In JPMorgan’s view, this puts them in an advantageous position to benefit from any recovery. 

    At the same time, those companies most exposed to the auto and tech industries, including German firm Infineon Technologies AG
    IFX,
    -0.96%

    and Swiss firm STMicroelectronics
    STM,
    -0.29%
    ,
    are set to continue trading at subdued levels — despite already being cheap — as the market remains challenging, they caution.

    Deshpande and the team noted that inventory levels for the chips used in the auto and industrial sectors currently sit at rates 38.7% higher than three-year seasonal averages in the fourth-quarter of 2023, marking a deterioration on the 31.1% rate in the third quarter of 2023.

    In contrast, inventory levels for memory chips improved significantly in the final three months of 2023, having fallen from rates 19% above seasonal averages in the third quarter to rates 1.7% below normal seasonal levels at the end of the fourth quarter of last year.

    For reference, ASML Holding, which was previously split off from ASM International in 1984 through a joint venture with Philips
    PHIA,
    -0.32%
    ,
    is currently the world’s sole manufacturer of the extreme ultraviolet lithography machines used to make the advanced chips used in the AI industry. 

    ASM International continues to design the wafer processing machines used to make microchips. VAT Group produces vacuum valves that are needed to manufacture high tech chips in sterile environments to ensure they are not exposed to outside particles.  

    Nvidia
    NVDA,
    -0.06%
    ,
    the world’s largest chip designer, will on Wednesday announce quarterly results, which investors are expected to pore over, seeking vital clues on the health of the global chip market amid much excitement around a possible AI driven boom. 

    Read: Nvidia’s earnings report could kill the momentum driving U.S. stocks higher, regardless of how it turns out.

    [ad_2]

    Source link

  • Amazon’s stock just racked up its highest close in more than two years

    Amazon’s stock just racked up its highest close in more than two years

    [ad_1]

    Amazon.com Inc. shares continued their charge higher Friday, securing their highest close in more than two years.

    The e-commerce giant’s stock advanced 2.7% in Friday’s session to finish the day at $174.45. That was the best ending level since Dec. 9, 2021, when Amazon’s stock
    AMZN,
    +2.71%

    closed at $147.17, according to Dow Jones Market Data.

    Don’t miss: Is Meta now a value stock?

    Amazon briefly surpassed Alphabet Inc.
    GOOG,
    +2.04%

    GOOGL,
    +2.12%

    as the third most valuable U.S. company by market capitalization last week, though it’s since fallen back to the No. 4 spot. Still, the recent momentum for Amazon shares has been enough to help the company hold down a place in the top four even as Nvidia Corp.
    NVDA,
    +3.58%

    nips at its heels.

    Alphabet finished Friday’s session with a $1.86 trillion market cap, while Amazon’s was $1.81 trillion and Nvidia’s was $1.78 trillion.

    Wall Street had a mixed reaction to earnings from big technology companies this quarter, but Amazon’s results were among those that were well received.

    See also: Amazon says the ‘magic words.’ They spurred a $130 billion market-cap boost.

    “Overall the overhangs which kept a lid on AMZN shares — e-commerce deceleration in 2021, e-commerce deceleration and margin compression in 2022 and AWS deceleration in 2023 — will have dissipated throughout 2024,” UBS analyst Stephen Ju wrote in a note to clients following those results.

    The company has been a huge driver of earnings growth for the S&P 500 consumer discretionary sector, as its quarterly earnings per share grew to $1 in the latest quarter from 3 cents a year before. The consumer discretionary sector is now expected to post 33% growth in EPS for the fourth quarter, according to FactSet, but without Amazon, that would swing to a decline of about 1%.

    [ad_2]

    Source link

  • Intel’s stock sees worst plunge since 2020: ‘Yet another major reset’

    Intel’s stock sees worst plunge since 2020: ‘Yet another major reset’

    [ad_1]

    As Intel Corp.’s stock plunged to its biggest one-day drop in about three and a half years, analysts had some harsh words for the chip maker.

    “How many times can you push the reset button?” Bernstein’s Stacy Rasgon asked in a note to clients.

    While he thought many investors were bracing for the company to miss on its first-quarter forecast, the outlook came in “extremely weak and clearly worse than feared.” Intel
    INTC,
    -11.91%

    expects $12.7 billion in revenue at the midpoint, while analysts had been looking for $14.3 billion.

    See more: Intel seen struggling to ‘find its footing’ as guidance miss sends stock tanking

    “After yet another major reset this story probably just shifted to 2026 at the earliest for the bulls, and there is a lot of meat for the bears to sink their teeth into in the meantime,” Rasgon wrote, while sticking with his market-perform rating and $42 target price.

    Baird’s Tristan Gerra highlighted challenges for Intel’s data-center and artificial-intelligence unit, which is “on track for a third consecutive year of revenue declines,” while his own revenue forecast implies a 14-year low.

    Gaudi, the company’s accelerator chip for artificial-intelligence applications, “does not seem enough to lift [data-center] revenue, while gross margin will be impacted by higher depreciation inclusive of an expected U.S. Chip Act credit,” Gerra continued.

    He also expressed some concerns about the company’s broader road ahead.

    “Can top-line growth in future years be sufficient to fund continued node migration?” Gerra said. “Many hurdles remain, notably ramping units from this year’s small base (small baseline for Intel 4 makes it more challenging to yield at the next node), while [the Intel Foundry Service] revenue ramp entirely depends on future node execution including yield and performance.”

    Gerra has a neutral rating and $40 target price on Intel’s stock.

    Shares fell 11.9% in Friday trading, making for their worst single-day percentage decline since July 24, 2020, when they fell 16.2%, according to Dow Jones Market Data.

    Needham’s N. Quinn Bolton, meanwhile, downgraded the stock to hold from buy in the wake of Thursday afternoon’s report, calling the earnings reset “unexpected.”

    “In addition to an overall worsening risk-reward, Intel’s core [data-center] business is challenged by a shift to accelerated computing architectures and direct competition from AMD and ARM,” he wrote. “We expect AI to remain the spending priority in the data center for the next several quarters. To that end, dollars will continue moving away from Intel’s core competency.”

    Read: Missed the boat on AMD’s stock surge? Why this analyst says you’re not too late.

    Rosenblatt’s Hans Mosesmann took a similar view as he argued that Intel’s sales outlook is “contrary to the uber bullish messaging to the Street and is consistent with share losses to AMD, a lack of any perceivable AI growth vector that moves any dial, and points to another, yes another, transitional year.”

    Artificial intelligence “seems like everywhere except at Intel,” he continued, noting that his stance on the stock “has not changed for many years.” Mosesmann continues to rate it at sell.

    Opinion: Intel’s stock plunge shows that Wall Street still hasn’t learned its lesson on AI hype

    Raymond James analyst Srini Pajjuri, however, was more upbeat about Intel’s ability to capitalize on AI. “While Intel won’t likely get much credit for AI in the near term, we are encouraged by the growing pipeline for Gaudi accelerators ($2b+) and expect meaningful revenue contribution” in the second half of 2024, he wrote, while sticking with his outperform call but cutting his target price to $52 from $54.

    [ad_2]

    Source link

  • So Long, Apple and Tesla. We Built a Better Magnificent 7.

    So Long, Apple and Tesla. We Built a Better Magnificent 7.

    [ad_1]

    In this article

    AMZN

    AAPL

    MSFT

    NVDA

    SPX

    The Magnificent Seven had an extraordinary year in 2023—one that will be very difficult to repeat. And there will be a new Magnificent Seven in 2024.

    Continue reading this article with a Barron’s subscription.

    View Options
    [ad_2]
    Source link

  • If Nvidia looked more like Salesforce, it might unlock billions more in cash

    If Nvidia looked more like Salesforce, it might unlock billions more in cash

    [ad_1]

    Nvidia Corp. is raking in billions in cash, but one analyst thinks the chip maker could throw $100 billion more onto the pile if it started to look more like Salesforce Inc.

    Nvidia
    NVDA,
    +2.29%

    might unlock even more cash by developing businesses that expand recurring revenue, according to BofA Securities analyst Vivek Arya. The company has suffered some boom-and-bust cycles in recent years, and another bust could be smoothed by developing longer-term software contracts akin to those of Salesforce
    CRM,
    -0.05%
    .
    , Workday Inc.
    WDAY,
    -0.48%

    and ServiceNow Inc.
    NOW,
    +0.64%
    ,
    which generate recurring revenue from their customers.

    Arya sees a pathway for Nvidia to rake in $100 billion in incremental free cash flow over the next two years if it can bulk up its own recurring-revenue options.

    Read: Apple’s stock needs to get ‘unstuck’ — and its innovation rut may not be helping

    “While NVDA has a solid lead in AI, hardware-oriented businesses are not valued as highly as visibility tends to be limited,” Arya wrote. Nvidia generates only about $1 billion, or 2%, of its sales from software and subscriptions. Arya doesn’t think the company can get much higher than $5 billion with its software and subscription offerings unless it turns to acquisitions.

    Nvidia has shown some openness to deals that would beef up its intellectual property and software offerings, Arya notes, as it tried to buy British chip designer Arm Holdings
    ARM,
    -1.96%

    before facing regulatory pushback.

    “We envision [Nvidia] considering more enhanced partnerships/M&A of software companies that are helping traditional enterprise customers deploy, monitor and analyze [generative AI] apps,” he wrote. Nvidia “is already serving them via on-premise hardware and/or its DGX cloud service, but we believe greater direct recurring software/service channel could be more impactful.”

    The addition of more recurring-revenue streams could help Nvidia’s “relatively depressed trading multiple,” in Arya’s view. Nvidia shares trade at a 20% to 30% discount to its “Magnificent Seven” peers on the basis of price to earnings as well as enterprise value to free cash flow, even though the company’s compound annual growth rate on the top line is three times what it is for those other tech giants.

    The discount is “partly due to uncertainty in [calendar 2025] growth prospects, and partly due to a very hardware-dependent business unlike other large-cap software/internet peers that have recurring-revenue profiles,” he wrote.

    Arya has a buy rating and $700 price objective on the stock.

    See also: Amazon’s stock could be helped by this secret weapon in 2024, BofA says

    [ad_2]

    Source link

  • The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks

    The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks

    [ad_1]

    The Russell 2000 Index soared 12% in December, which might reflect investors’ exuberance about the state of the U.S. economy — it appears the Federal Reserve has won its battle against inflation.

    But if you are looking to broaden your exposure to the stock market beyond the large-cap S&P 500
    SPX,
    buying shares of a fund that tracks the Russell 2000 Index
    RUT
    might not be the best way to do it. This is because the Russell 2000 isn’t selective — it is made up of the smallest 2,000 companies by market capitalization in the Russell 3000 Index
    RUA,
    which itself is designed to capture about 98% of the U.S. public equity market.

    A better choice might be the S&P Small Cap 600 Index
    SML
    because S&P Global requires companies to show four consecutive quarters of profitability to be initially included in the index, among other criteria.

    Below is a screen of analysts’ favorite stocks among the S&P Small Cap 600, along with another for the Russell 2000.

    Watch for a “head fake”

    Much of the small-cap buying in December might have resulted from covering of short positions by hedge-fund managers. This idea is backed by the timing of trading activity immediately following the Federal Open Market Committee’s announcement on Dec. 13 that it wouldn’t change its interest-rate policy, according to MacroTourist blogger Kevin Muir. The Fed’s economic projections released the same day also indicate three cuts to the federal-funds rate in 2024.

    Heading into the end of the year, a fund manager who had shorted small-caps, and then was surprised by the Fed’s interest-rate projections, might have scrambled to buy stocks it had shorted to close-out the positions and hopefully lock in gains, or limit losses.

    That buying activity and resulting pop in small-cap prices could set up a typical “head fake” for investors as the new year begins, according to Muir.

    The long-term case for quality

    Looking at data for companies’ most recently reported fiscal quarters, 58% of the Russell 2000 reported positive earnings per share, according to data provided by FactSet. In other words, hundreds of these companies were losing money. These might include promising companies facing “binary events,” such as make-or-break drug trials in the biotechnology industry.

    In comparison, 78% of companies among the S&P Small Cap 600 were profitable, and 93% of the S&P 500 were in the black.

    Here are long-term performance figures for exchange-traded funds that track all three indexes:

    ETF

    Ticker

    2023

    3 years

    5 years

    10 years

    15 years

    20 years

    iShares Russell 2000 ETF

    IWM 17%

    7%

    61%

    99%

    428%

    365%

    iShares Core S&P Small Cap ETF

    IJR 16%

    25%

    69%

    129%

    540%

    515%

    SPDR S&P 500 ETF Trust

    SPY 26%

    34%

    108%

    210%

    629%

    527%

    Source: FactSet

    An approach tracking the S&P Small Cap 600 has outperformed the Russell 2000 for all periods, with margins widening as you go further back.

    Brett Arends: You own the wrong small-cap fund. How to get into a better one.

    Looking ahead for quality… or not

    For the first screen, we began with the S&P Small Cap 600 and narrowed the list to 385 companies covered by at least five analysts polled by FactSet. Then we cut the list to 92 companies with “buy” or equivalent ratings among at least 75% of the covering analysts.

    Here are the 20 remaining stocks among the S&P Small Cap 600 with the highest 12-month upside potential indicated by analysts’ consensus price targets:

    Company

    Ticker

    Share “buy” ratings

    Dec. 29 price

    Consensus price target

    Implied 12-month upside potential

    Vir Biotechnology Inc.

    VIR,
    +4.47%
    88%

    $10.06

    $32.00

    218%

    Arcus Biosciences Inc.

    RCUS,
    +3.04%
    82%

    $19.10

    $41.00

    115%

    Xencor Inc.

    XNCR,
    +6.03%
    92%

    $21.23

    $39.83

    88%

    Dynavax Technologies Corp.

    DVAX,
    +2.86%
    100%

    $13.98

    $24.80

    77%

    ModivCare Inc.

    MODV,
    +0.95%
    100%

    $43.99

    $75.50

    72%

    Xperi Inc

    XPER,
    +1.81%
    80%

    $11.02

    $18.20

    65%

    Thryv Holdings Inc.

    THRY,
    100%

    $20.35

    $32.75

    61%

    Ligand Pharmaceuticals Inc.

    LGND,
    +1.25%
    100%

    $71.42

    $114.80

    61%

    Green Plains Inc.

    GPRE,
    -1.67%
    80%

    $25.22

    $40.30

    60%

    Patterson-UTI Energy Inc.

    PTEN,
    +0.28%
    75%

    $10.80

    $17.00

    57%

    Ironwood Pharmaceuticals Inc. Class A

    IRWD,
    +8.48%
    83%

    $11.44

    $17.83

    56%

    Catalyst Pharmaceuticals Inc.

    CPRX,
    +1.78%
    100%

    $16.81

    $26.20

    56%

    Payoneer Global Inc.

    PAYO,
    -3.45%
    100%

    $5.21

    $8.00

    54%

    Helix Energy Solutions Group Inc.

    HLX,
    -2.63%
    83%

    $10.28

    $15.00

    46%

    Arlo Technologies Inc.

    ARLO,
    -3.05%
    100%

    $9.52

    $13.80

    45%

    Pacira Biosciences Inc.

    PCRX,
    -5.16%
    100%

    $33.74

    $48.40

    43%

    Privia Health Group Inc.

    PRVA,
    +2.95%
    100%

    $23.03

    $32.53

    41%

    Semtech Corp.

    SMTC,
    -1.23%
    92%

    $21.91

    $30.90

    41%

    Talos Energy Inc.

    TALO,
    +1.19%
    78%

    $14.23

    $20.00

    41%

    Digi International Inc.

    DGII,
    -1.21%
    100%

    $26.00

    $36.14

    39%

    Source: FactSet

    Any stock screen should only be considered a starting point. You should do your own research to form your own opinion before making any investment. one way to begin is by clicking on the tickers for more about each company.

    Click here for Tomi Kilgore’s detailed guide to the wealth of information available for free on the MarketWatch quote page.

    Moving on to the Russell 2000, when we narrowed this group to stocks covered by at least five analysts polled by FactSet, we were left with 936 companies. Among these, 355 have “buy” or equivalent ratings among at least 75% of the covering analysts.

    Among those 355 stocks in the Russell 2000, these 20 have the highest implied upside over the next year, based on consensus price targets:

    Company

    Ticker

    Share “buy” ratings

    Dec. 29 price

    Consensus price target

    Implied 12-month upside potential

    Karyopharm Therapeutics Inc.

    KPTI,
    +4.18%
    75%

    $0.87

    $6.00

    594%

    Rallybio Corp.

    RLYB,
    +0.42%
    100%

    $2.39

    $16.50

    590%

    Vor Biopharma Inc.

    VOR,
    -0.89%
    100%

    $2.25

    $15.44

    586%

    Tenaya Therapeutics Inc.

    TNYA,
    -0.62%
    100%

    $3.24

    $19.14

    491%

    Compass Therapeutics Inc.

    CMPX,
    -5.13%
    86%

    $1.56

    $9.17

    488%

    Vigil Neuroscience Inc.

    VIGL,
    +2.66%
    88%

    $3.38

    $18.75

    455%

    Trevi Therapeutics Inc.

    TRVI,
    -2.99%
    100%

    $1.34

    $7.33

    447%

    Inozyme Pharma Inc.

    INZY,
    +1.64%
    100%

    $4.26

    $21.00

    393%

    Gritstone bio Inc.

    GRTS,
    +6.86%
    100%

    $2.04

    $10.00

    390%

    Actinium Pharmaceuticals Inc.

    ATNM,
    +4.72%
    83%

    $5.08

    $23.36

    360%

    Lineage Cell Therapeutics Inc.

    LCTX,
    86%

    $1.09

    $4.83

    343%

    Century Therapeutics Inc.

    IPSC,
    +9.64%
    86%

    $3.32

    $14.67

    342%

    Acrivon Therapeutics Inc.

    ACRV,
    +1.83%
    100%

    $4.92

    $21.13

    329%

    Avidity Biosciences Inc.

    RNA,
    +1.22%
    100%

    $9.05

    $37.50

    314%

    Longboard Pharmaceuticals Inc.

    LBPH,
    +316.25%
    100%

    $6.03

    $24.17

    301%

    Omega Therapeutics Inc.

    OMGA,
    -1.33%
    100%

    $3.01

    $12.00

    299%

    Allogene Therapeutics Inc.

    ALLO,
    +12.77%
    82%

    $3.21

    $12.79

    298%

    X4 Pharmaceuticals Inc.

    XFOR,
    +5.21%
    86%

    $0.84

    $3.26

    289%

    Caribou Biosciences Inc.

    CRBU,
    -2.79%
    89%

    $5.73

    $22.25

    288%

    Stoke Therapeutics Inc.

    STOK,
    +11.41%
    78%

    $5.26

    $19.33

    268%

    Source: FactSet

    That’s right — this Russell 2000 list is all biotech. And in case you are wondering if any companies are on both lists, the answer is no.

    Don’t miss: 11 dividend stocks with high yields expected to be well supported in 2024 per strict criteria

    [ad_2]

    Source link

  • These 20 stocks soared the most in 2023

    These 20 stocks soared the most in 2023

    [ad_1]

    (Updated with Friday’s closing prices.)

    The 2023 rally for stocks in the U.S. accelerated as more investors bought the idea that the Federal Reserve succeeded in its effort to bring inflation to heel.

    The S&P 500
    SPX
    ended Friday with a 24.2% gain for 2023, following a 19.4% decline in 2022. (All price changes in this article exclude dividends). Among the 500 stocks, 65% were up for 2023. Below is a list of the year’s 20 best performers in the benchmark index.

    This article focuses on large-cap stocks. MarketWatch Editor in Chief Mark DeCambre took a broader look at all U.S. stocks of companies with market capitalizations of at least $1 billion, to list 10 with gains ranging from 412% to 1,924%.

    The Fed began raising short-term interest rates and pushing long-term rates higher in March 2022 by allowing its bond portfolio to run off. That explains the poor performance for stocks in 2022, as bonds and even bank accounts because more attractive to investors.

    The central bank hasn’t raised the federal-funds rate since moving it to the current target range of 5.25% to 5.50% in July, and its economic projections point to three rate cuts in 2024.

    Investors are anticipating the return to a low-rate environment by scooping up 10-year U.S. Treasury notes
    BX:TMUBMUSD10Y,
    whose yield ended the year at 3.88%, down from 4.84% on Oct. 27 — the day of the S&P 500’s low for the second half of 2023.

    Read: Treasury yields end mostly higher but little changed on year after wild 2023

    Before looking at the list of best-performing stocks of 2023, here’s a summary of how the 11 sectors of the S&P 500 performed, with the full index and three more broad indexes at the bottom:

    Sector or index

    2023 price change

    2022 price change

    Price change since end of 2021

    Forward P/E

    Forward P/E at end of 2022

    Forward P/E at end of 2023

    Information Technology

    56.4%

    -28.9%

    11.5%

    26.7

    20.0

    28.2

    Communication Services

    54.4%

    -40.4%

    -7.6%

    17.4

    14.3

    21.0

    Consumer Discretionary

    41.0%

    -37.6%

    -11.4%

    26.2

    21.7

    34.7

    Industrials

    16.0%

    -7.1%

    8.0%

    20.0

    18.7

    22.0

    Materials

    10.2%

    -14.1%

    -4.9%

    19.5

    15.8

    16.6

    Financials

    9.9%

    -12.4%

    -3.4%

    14.6

    13.0

    16.3

    Real Estate

    8.3%

    -28.4%

    -21.6%

    18.3

    16.9

    24.7

    Healthcare

    0.3%

    -3.6%

    -3.3%

    18.2

    17.7

    17.3

    Consumer Staples

    -2.2%

    -3.2%

    -5.4%

    19.3

    20.6

    21.4

    Energy

    -4.8%

    59.0%

    51.8%

    10.9

    9.8

    11.1

    Utilities

    -10.2%

    -1.4%

    -11.4%

    15.9

    18.7

    20.4

    S&P 500
    SPX
    24.2%

    -19.4%

    0.4%

    19.7

    16.8

    21.6

    Dow Jones Industrial Average
    DJIA
    13.7%

    -8.8%

    3.8%

    17.6

    16.6

    18.9

    Nasdaq Composite
    COMP
    43.4%

    -33.1%

    -3.5%

    26.9

    22.6

    32.0

    Nasdaq-100
    NDX
    53.8%

    -33.0%

    3.5%

    26.3

    20.9

    30.3

    Source: FactSet

    A look at 2023 price action really needs to encompass what took place in 2022 for context. The broad indexes haven’t moved much from their levels at the end of 2022 (again, excluding dividends). We have included current forward price-to-earnings ratios along with those at the end of 2021 and 2022. These valuations have declined a bit, which may provide some comfort for investors wondering how likely it is for stocks to continue to rally in 2024.

    Biggest price increases among the S&P 500

    Here are the 20 stocks in the S&P 500 whose prices rose the most in 2023:

    Company

    Ticker

    2023 price change

    2022 price change

    Price change since end of 2021

    Forward P/E

    Forward P/E at end of 2022

    Forward P/E at end of 2021

    Nvidia Corp.

    NVDA,
    239%

    -50%

    68%

    24.9

    34.4

    58.0

    Meta Platforms Inc. Class A

    META,
    -1.22%
    194%

    -64%

    5%

    20.2

    14.7

    23.5

    Royal Caribbean Group

    RCL,
    -0.37%
    162%

    -36%

    68%

    14.3

    14.9

    232.4

    Builders FirstSource Inc.

    BLDR,
    -1.02%
    157%

    -24%

    95%

    14.2

    10.7

    13.3

    Uber Technologies Inc.

    UBER,
    -2.49%
    149%

    -41%

    47%

    56.9

    N/A

    N/A

    Carnival Corp.

    CCL,
    -0.70%
    130%

    -60%

    -8%

    18.7

    41.3

    N/A

    Advanced Micro Devices Inc.

    AMD,
    -0.91%
    128%

    -55%

    2%

    39.7

    17.7

    43.1

    PulteGroup Inc.

    PHM,
    -0.26%
    127%

    -20%

    81%

    9.1

    6.3

    6.2

    Palo Alto Networks Inc.

    PANW,
    -0.24%
    111%

    -25%

    59%

    50.2

    38.0

    70.1

    Tesla Inc.

    TSLA,
    -1.86%
    102%

    -65%

    -29%

    66.2

    22.3

    120.3

    Broadcom Inc.

    AVGO,
    -0.55%
    100%

    -16%

    68%

    23.2

    13.6

    19.8

    Salesforce Inc.

    CRM,
    -0.92%
    98%

    -48%

    4%

    28.0

    23.8

    53.5

    Fair Isaac Corp.

    FICO,
    -0.46%
    94%

    38%

    168%

    47.1

    29.3

    28.7

    Arista Networks Inc.

    ANET,
    -0.62%
    94%

    -16%

    64%

    32.7

    22.3

    41.4

    Intel Corp.

    INTC,
    -0.28%
    90%

    -49%

    -2%

    26.6

    14.6

    13.9

    Jabil Inc.

    JBL,
    -0.45%
    87%

    -3%

    81%

    13.5

    7.9

    10.3

    Lam Research Corp.

    LRCX,
    -0.81%
    86%

    -42%

    9%

    25.2

    13.5

    20.2

    ServiceNow Inc.

    NOW,
    +0.57%
    82%

    -40%

    9%

    56.0

    42.6

    90.1

    Amazon.com Inc.

    AMZN,
    -0.94%
    81%

    -50%

    -9%

    42.0

    46.7

    64.9

    Monolithic Power Systems Inc.

    MPWR,
    -0.23%
    78%

    -28%

    28%

    49.1

    27.3

    57.9

    Source: FactSet

    Click on the tickers for more about each company.

    Click here for Tomi Kilgore’s detailed guide to the wealth of information available for free on the MarketWatch quote page.

    Don’t miss: Nvidia tops list of Wall Street’s 20 favorite stocks for 2024

    [ad_2]

    Source link

  • Intel Rallied 91% This Year. Expect Higher Highs in 2024.

    Intel Rallied 91% This Year. Expect Higher Highs in 2024.

    [ad_1]

    What a strange year 2023 was for Intel

    Continue reading this article with a Barron’s subscription.

    View Options
    [ad_2]
    Source link

  • Intel, Tesla, Apple, Iovance, NetEase, Coherus BioSciences, and More Stock Market Movers

    Intel, Tesla, Apple, Iovance, NetEase, Coherus BioSciences, and More Stock Market Movers

    [ad_1]

    Stock futures traded slightly lower Wednesday after the S&P 500 finished higher Tuesday and just 0.45% below its record close of 4,796.56 hit Jan. 3, 2022. The broad market index has risen 24% this year and has gained 4.5% this month as traders bet the Federal Reserve will begin cutting interest rates as soon as March.

    Continue reading this article with a Barron’s subscription.

    View Options

    [ad_2]

    Source link

  • Synopsys and Ansys in talks to merge: report

    Synopsys and Ansys in talks to merge: report

    [ad_1]

    Shares of Ansys Inc. soared 18% in trading Friday on reports the company is in discussions to be acquired by Synopsys Inc. in a deal that would create a design-software behemoth.

    The potential deal would kick off 2024 with a mega-merger, even as the Federal Trade Commission attempts to crack down on such transactions. Talks remain fluid and a third party might still emerge as a possible suitor of Ansys, according to a Wall Street Journal report, which cited people familiar with the situation.

    Ansys
    ANSS,
    +18.08%
    ,
    which has a market value of nearly $26.3 billion, makes software that helps predict how products in aerospace, healthcare and automotive applications will work in the real world. A deal could be struck early in 2024, according to people familiar with the matter. Ansys reported revenue of $2.1 billion in 2022.

    Synopsys
    SNPS,
    -6.34%
    ,
    with a market value of $85.1 billion, makes software that engineers use to design and test silicon chips used in smartphones, self-driving cars and other forms of artificial intelligence. Its stock has climbed 65% this year as investors have hopped on the AI bandwagon boom. Shares of Synopsys dipped 6% in late trading Friday.

    Synopsys’s customers include Nvidia Corp.
    NVDA,
    -0.33%
    ,
    Intel Corp.
    INTC,
    +1.95%

    and Advanced Micro Devices Inc.
    AMD,
    -0.22%
    .

    Representatives from Synopsys and Ansys were not immediately available for comment.

    Should the companies strike a merger, it would offer a fresh test for the FTC and its chair, Lina Khan, who have opposed large tech mergers and acquisitions. The agency unsuccessfully sued Facebook parent Meta Platforms Inc.
    META,
    -0.20%

    in its pursuit of VR developer Within, as well as Microsoft Corp.’s
    MSFT,
    +0.28%

    $69 billion purchase of Activision Blizzard Inc.

    [ad_2]

    Source link

  • Alphabet, Heico, Bluebird Bio, Plug Power, UBS, FedEx, and More Stock Market Movers

    Alphabet, Heico, Bluebird Bio, Plug Power, UBS, FedEx, and More Stock Market Movers

    [ad_1]

    Stock futures traded flat Tuesday, a day after the S&P 500 finished up 0.5% and moved closer to its all-time. The broad market index stands just 1.2% below its record of 4,796.56 reached in early January 2022.

    Continue reading this article with a Barron’s subscription.

    View Options

    [ad_2]

    Source link

  • Broadcom now ranks among 10 largest U.S. companies after big 2023 stock gains

    Broadcom now ranks among 10 largest U.S. companies after big 2023 stock gains

    [ad_1]

    Nvidia Corp. has catapulted up the list of the most valuable U.S. companies this year, rising eight spots from the end of last year to sit in the fifth position with a market capitalization of $1.2 trillion.

    But other chip companies have seen their positions rise even more. Just look at Broadcom Inc.
    AVGO,
    +2.10%
    ,
    which has climbed 16 spots over the course of 2023 and on Friday cracked the top 10 for the first time, according to Dow Jones Market Data. Broadcom eclipsed Visa Inc.
    V,
    -0.27%

    at Friday’s close to take the No. 10 spot, with a valuation of $527.7 billion.

    Read: Could Nvidia’s stock — up 231% this year — actually be a bargain?

    Admittedly, Broadcom had some help along the way. The company acquired VMware in late November, and its market capitalization gained about $50 billion at the close of the transaction, according to FactSet data.

    But Broadcom’s ascent also reflects how chip stocks have gotten more shine this year amid the artificial-intelligence frenzy. Broadcom’s stock has doubled so far in 2023.

    Mizuho desk-based analyst Jordan Klein expects “an order acceleration in networking silicon for AI clusters” in the second half of 2024, as calendar year 2025 could bring a big year of capital-expenditure investments in AI for ethernet back-end high-speed connections.

    Broadcom “is the KEY WINNER in that investment cycle as the arms dealer to all networking OEMs,” or original equipment manufacturers, wrote Klein, who’s associated with Mizuho’s sales team and not its research arm.

    Advanced Micro Devices Inc.
    AMD,
    +0.83%

    has also seen a nice march up the charts, rising 48 spots so far in 2023 to rank 30th in terms of market cap. AMD was valued at $223.9 billion as of Friday’s close.

    “We view AMD as well-positioned to gain incremental share of the hugely profitable $100 billion-plus accelerator market while continuing to make progress in server [central processing units] against incumbent [Intel],” BofA Securities analyst Vivek Arya wrote in a recent upgrade.

    [ad_2]

    Source link

  • AMD Stock Is More Expensive Than Nvidia. That Makes No Sense.

    AMD Stock Is More Expensive Than Nvidia. That Makes No Sense.

    [ad_1]

    Advanced Micro Devices is on a roll this week, with its shares marching higher since the chip maker revealed ambitious plans to push into artificial intelligence. Investors looking to dive in best be warned: the stock now looks more expensive than Nvidia.

    Continue reading this article with a Barron’s subscription.

    View Options
    [ad_2]
    Source link